UK Dermatological Therapeutics Market Analysis

UK Dermatological Therapeutics Market Analysis


$ 3999

UK Dermatological Therapeutics Market is at around $1.04 Bn in 2023 and is projected to reach $1.63 Bn in 2030, exhibiting a CAGR of 6.6% during the forecast period. The market is driven by the rising prevalence of skin disorders, developments in dermatology research and technology, and patient awareness and education. The market is dominated by key players like LEO Pharma, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, Gladerma Laboratories, Johnson & Johnson, Eli Lilly and Company, and GlaxoSmithKline Plc.

ID: IN10GBPH035 CATEGORY: Pharmaceuticals GEOGRAPHY: UK AUTHOR: Aneri Parekh

Buy Now

UK Dermatological Therapeutics Market Executive Summary

UK Dermatological Therapeutics Market is at around $1.04 Bn in 2023 and is projected to reach $1.63 Bn in 2030, exhibiting a CAGR of 6.6% during the forecast period.

To enhance skin health and treat ailments like dermatitis, psoriasis, and acne, dermatological therapy includes the diagnosis and treatment of skin problems. This area addresses a variety of dermatological issues by combining medications, cutting-edge technologies, and lifestyle modifications.

The rise in skin problems and dermatological conditions is fueling the continuous growth of the UK Dermatological Therapeutics Market. The aging of the population and advances in research and development are factors driving market expansion. To stay ahead of the competition in this fast-paced healthcare market, major businesses are concentrating on cutting-edge treatment alternatives and tactical alliances.

Revenue generated by dermatological treatments worldwide increased to $40.94 Bn in 2023. This enormous growth, a sign of a shifting society, is made possible by modern technology and industrial processes that are incredibly efficient. Higher investment, continuous innovation, and enhanced accessibility are some of the reasons behind the company's explosive growth. The market for dermatological treatments has grown as a result of these factors.

LEO Pharma is a prominent player in the UK dermatology medicines industry, having established a niche presence and exhibiting encouraging growth. LEO Pharma's expertise and brand familiarity are strengthened by its focused attention to skin diseases. With a considerable market share, their flagship biologic, Adtralza (tralokinumab), has become popular as a first-line treatment for moderate-to-severe atopic dermatitis.

UK dermatological therapeutics market

Market Dynamics

Market Growth Drivers:

Growing Prevalence of Skin Disorders: The market for dermatological therapies is significantly influenced by the increased prevalence of skin disorders such as psoriasis, acne, eczema, and skin cancer. The need for efficient therapies for various illnesses is projected to rise as the population ages and lifestyles alter.

Developments in Dermatology Research and Technology: New and more potent treatment alternatives are created as a result of ongoing dermatological research and technological breakthroughs. The market is expanding as a result of advancements in topical therapies, biologics, and drug delivery systems.

Patient Education and Awareness: Educating patients about their options for therapy and raising their awareness of skin health issues might help grow the market for dermatological treatments. Patients are seeking out and sticking with dermatological treatments more proactively these days.

Market Restraints:

Regulatory Hurdles: The pharmaceutical industry's strict rules and compliance demands might make it difficult to develop and approve dermatological treatments.

Market Competition: Market share and profitability of particular pharmaceutical products may be restricted by fierce competition among pharmaceutical corporations. Sales may also be impacted by generic alternatives and market saturation.

Global Economic Conditions: Consumer expenditure on healthcare items might be impacted by economic downturns and uncertainty, which could affect the market's growth for dermatological treatments.

Healthcare Policies and Regulatory Landscape

Pharmaceuticals are regulated in the UK by the Medicines and Healthcare Products Regulatory Agency (MHRA). The executive agency known as MHRA is sponsored by the Department of Health and Social Care. The regulatory agency reviews clinical research to make sure the drug is safe, effective, and meets manufacturing quality standards. If they are satisfied, a license or marketing authorization is given. This enables the license holder to offer the product for sale in the regions under the regulatory body's jurisdiction. Thorough regulatory assessments, extensive clinical research, and adherence to the stringent safety and efficacy requirements set forth by the Medicines and Healthcare Products Regulatory Agency (MHRA) are all present. Completing these processes demands a significant amount of time and resources, which occasionally results in delays and challenges when introducing new drugs into the market.

Competitive Landscape

Key Players:

  • LEO Pharma
  • Almirall SA
  • Pfizer Inc.
  • AbbVie Inc.
  • Amgen Inc.
  • Novartis AG
  • Gladerma Laboratories
  • Johnson & Johnson
  • Eli Lilly and Company
  • GlaxoSmithKline Plc.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

UK Dermatological Therapeutics Market Segmentation

By Type

  • Prescription-based Drugs
  • Over-the-counter Drugs

By Disease

  • Alopecia
  • Herpes
  • Psoriasis
  • Rosacea
  • Skin Cancer
  • Acne
  • Atopic Dermatitis
  • Vitiligo
  • Hidradenitis
  • Other Applications

By Drug Class

  • Anti-infectives
  • Corticosteroids
  • Anti-acne
  • Calcineurin Inhibitors
  • Retinoids
  • Other Drug Classes

By Route of Administration

  • Topical Administration
  • Oral Administration
  • Parenteral Administration

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 22 February 2024
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up